Saturday, April 13, 2024
HomeNewsBusiness WireAccel Research Sites Network acquires 2 new locations

Accel Research Sites Network acquires 2 new locations

Clinical trial leader will now serve Ormond Beach, Edgewater in Florida

ORLANDO, Fla.–(BUSINESS WIRE)–Accel Research Sites Network has always been dedicated to bringing innovative treatments to a variety of patients through cutting-edge clinical trials. The company will now be able to serve an even larger population, expanding its community reach.

The clinical trial leader announced the acquisition of two new site locations in Ormond Beach, Fla., and Edgewater, Fla, bringing the company’s total number of sites to 25. The sites—Ormond Medical Arts (OMA)-Pharmaceutical Research Center, formerly Complete Health Research—will now be known as Accel Research Sites Ormond Beach and Accel Research Sites Edgewater.

“Our mission and vision centers around patients, partners and people,” said Lora Parahovnik, CEO of Accel Research Sites. “We are thrilled that the addition of these sites means we will be able to work with outstanding providers, deepen our already talented team, and most importantly, reach even more patients in communities who can benefit from innovative treatment and research.”

The new sites have expertise in clinical trials for women’s health, migraine, dermatology, osteoarthritis, blood/specimen collections, pulmonology, diabetes, hypertension, and hyperlipidemia. Both sites have access to a local lab and two area imaging facilities for CT, DEXA, mammogram, ultrasounds and X-rays. The Edgewater location also has capabilities for infusions.

The acquisition also means the addition of six experienced principal investigators to the Accel team, as well as clinical staff members.

Both sites are strategically placed in the greater Central Florida area close enough to be supported by Accel’s central functions, but still mean Accel will have the chance to serve expanded patient populations in Florida. The Edgewater site, particularly, is strategically placed to provide exciting treatment options to a community that might not otherwise have access.

Over Parahovnik’s tenure, the company has tripled its locations, servicing an area of Florida across the I-4 corridor, as well as offering several locations in the Birmingham, Ala., and Atlanta, Ga., areas.

For more information, visit

About Accel Research Sites Network

Accel Research Sites Network is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.


Will Wellons

Wellons Communications



Caribbean News

Taiwan – US signs arrangement on technical cooperation in the Caribbean

By Caribbean News Global TAIWAN / USA / THE CARIBBEAN - Taiwan’s Representative to the United States ambassador Alexander Tah-Ray Yui and American Institute...

Global News

Afreximbank delivers exceptional financial results in 2023 … well ahead of expectations

CAIRO, Egypt – African Export-Import Bank (“Afreximbank” or the “Group”) has released the consolidated financial statements of the bank and its subsidiaries for the year...